Myriad Tells Justices To Reject ACLU Gene Patent Challenge
Myriad Genetics Inc. urged the U.S. Supreme Court on Wednesday not to hear a challenge to its breast cancer gene patents, saying that the Federal Circuit correctly held that isolated DNA...To view the full article, register now.
Already a subscriber? Click here to view full article